Neerupudi K. Babu
Mohali, PB 160062, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Indolylmaleimide derivatives as a new class of anti-leishmanial agents: synthesis and biological evaluation.
Journal: RSC medicinal chemistry
Published: February 11, 2025
Repurposing of propafenone, an FDA approved anti-arrhythmic drug for antileishmanial therapy.
Journal: Biochimie
Published: August 26, 2024
Pyridoxal kinase gene deletion leads to impaired growth, deranged redox metabolism and cell cycle arrest in Leishmania donovani.
Journal: Biochimie
Published: September 14, 2023
Leishmania donovani 6-phosphogluconolactonase: Crucial for growth and host infection?
Journal: Microbial pathogenesis
Published: January 10, 2023
Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies.
Journal: RSC medicinal chemistry
Published: October 16, 2021
Biochemical and inhibition studies of glutamine synthetase from Leishmania donovani.
Journal: Microbial pathogenesis
Published: November 10, 2016
Identification and characterization of a novel Ribose 5-phosphate isomerase B from Leishmania donovani.
Journal: Biochemical and biophysical research communications
Published: March 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026